Even within the same tumor, some CSC clones can express high levels of drug efflux transporters, DNA repair enzymes, and antiapoptotic proteins, enabling them to survive treatment, whereas others cannot.434 Over time, this selective pressure enriches resistant CSC clones, leading to tumor recurrence and therapy failure. Here, LIG4 is linked to neoplasm.